Page last updated: 2024-08-22

zirconium and Adverse Drug Event

zirconium has been researched along with Adverse Drug Event in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boellaard, R; Börjesson, PK; Castelijns, JA; de Bree, R; Jauw, YW; Leemans, CR; Roos, JC; van Dongen, GA	1

Trials

1 trial(s) available for zirconium and Adverse Drug Event

Article	Year
Radiation dosimetry of 89Zr-labeled chimeric monoclonal antibody U36 as used for immuno-PET in head and neck cancer patients. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2009, Volume: 50, Issue:11 Topics: Aged; Antibodies, Monoclonal; Bone Marrow; Carcinoma, Squamous Cell; Clinical Trials as Topic; Drug-Related Side Effects and Adverse Reactions; Female; Head and Neck Neoplasms; Humans; Isotope Labeling; Male; Middle Aged; Positron-Emission Tomography; Radiation Dosage; Radioisotopes; Radiometry; Recombinant Fusion Proteins; Tissue Distribution; Zirconium	2009

Article

Year

Radiation dosimetry of 89Zr-labeled chimeric monoclonal antibody U36 as used for immuno-PET in head and neck cancer patients.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2009, Volume: 50, Issue:11

Topics: Aged; Antibodies, Monoclonal; Bone Marrow; Carcinoma, Squamous Cell; Clinical Trials as Topic; Drug-Related Side Effects and Adverse Reactions; Female; Head and Neck Neoplasms; Humans; Isotope Labeling; Male; Middle Aged; Positron-Emission Tomography; Radiation Dosage; Radioisotopes; Radiometry; Recombinant Fusion Proteins; Tissue Distribution; Zirconium

2009